查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1195397

多汗症治療的全球市場:趨勢，預測，競爭分析

Hyperhidrosis Treatment Report: Trends, Forecast and Competitive Analysis
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球多汗症治療的市場規模，從2023年到2028年預計以4％～6％的年複合成長率成長。全球多汗症治療市場，未來在醫院和門診手術中心市場上預計有機會。還有這個市場主要促進因素，是個人的憂鬱症和焦慮症的盛行率增加，人口增加，及高有效率治療的崛起。

本報告提供全球多汗症治療市場相關調查分析，市場動態，各市場區隔、各地區的市場趨勢與預測分析，競爭分析，企業簡介等資訊。

目錄

第1章 摘要整理

第2章 全球多汗症治療市場:市場動態

  • 簡介，背景，分類
  • 供應鏈
  • 產業的推動因素與課題

第3章 市場趨勢與預測分析(2017年～2028年)

  • 宏觀經濟趨勢(2017年～2022年)與預測(2023年～2028年)
  • 全球多汗症治療市場趨勢(2017年～2022年)與預測(2023年～2028年)
  • 全球多汗症治療市場:各治療類型
    • 肉毒桿菌A
    • 離子電滲療法
    • 外科的治療
    • 局部治療
    • 汗腺的非外科的微波能量破壞
    • 其他
  • 全球多汗症治療市場:各多汗症類型
    • 腋下多汗症
    • 手掌多汗症
    • 腳底多汗症
    • 其他
  • 全球多汗症治療市場:各流通管道
    • 醫院藥局
    • 零售藥局
    • 線上藥局
  • 全球多汗症治療市場:各終端用戶
    • 醫院
    • 門診病人手術中心
    • 其他(皮膚科診所、化妝品中心)

第4章 市場趨勢與預測分析:各地區(2017年～2028年)

  • 全球多汗症治療市場:各地區
  • 北美
    • 各治療類型
    • 各多汗症類型
  • 歐洲
    • 各治療類型
    • 各多汗症類型
  • 亞太地區
    • 各治療類型
    • 各多汗症類型
  • 其他地區
    • 各治療類型
    • 各多汗症類型

第5章 競爭的分析

  • 產品系列分析
  • 業務整合
  • 波特的五力分析

第6章 成長機會及策略分析

  • 成長機會分析
    • 各治療類型
    • 各多汗症類型
    • 各流通管道
    • 各終端用戶
    • 各地區
  • 全球市場的新興趨勢
  • 策略分析
    • 新產品的開發
    • 生產能力擴大
    • 合併，收購，合資企業
    • 檢定和授權

第7章 主要企業簡介

  • Brickell Biotech Inc.
  • Allergan PLC.
  • Cynosure
  • Dermira Inc
  • Dermadry Laboratories Inc
  • GlaxoSmithKline PLC
  • Sesderma
  • Miramar Labs Inc
  • Ulthera Inc .
簡介目錄

Hyperhidrosis Treatment Market Trends and Forecast

The future of the global hyperhidrosis treatment market looks promising with opportunities in the hospitals and ambulatory surgical center market. The global hyperhidrosis treatment market is expected to grow with a CAGR of 4% to 6% from 2023 to 2028. The major drivers for this market are growing prevalence of depression and anxiety among individuals, increasing population, and rising advanced and efficient treatment.

Hyperhidrosis Treatment Market

A more than 150-page report is developed to help in your business decisions.  Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global hyperhidrosis treatment market report.

Hyperhidrosis Treatment Market by Segments

Hyperhidrosis Treatment Market by Segment

The study includes a forecast for the global hyperhidrosis treatment market by treatment type, hyperhidrosis type, distribution channel, end use industry, and region as follows:

Hyperhidrosis Treatment Market by Treatment Type [Value ($B) Shipment Analysis from 2017 to 2028]:

Botulinum Toxin A

Iontophoresis

Surgical Treatments

Topical Treatments

Non-surgical Microwave Energy Destruction of Sweat Glands

Others

Hyperhidrosis Treatment Market by Hyperhidrosis Type [Value ($B) Shipment Analysis from 2017 to 2028]:

Axillary Hyperhidrosis

Palmar Hyperhidrosis

Plantar Hyperhidrosis

Others

Hyperhidrosis Treatment Market by Distribution Channel [Value ($B) Shipment Analysis from 2017 to 2028]:

Hospital pharmacies

Retail pharmacies

Online pharmacies

Hyperhidrosis Treatment Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

Hospitals

Ambulatory Surgical Centers

Others (Dermatology Clinics and Cosmetic Centers)

Hyperhidrosis Treatment Market by Region [Value ($B) shipment analysis for 2017-2028]:

North America

Europe

Asia Pacific

The Rest of the World

List of Hyperhidrosis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hyperhidrosis treatment companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hyperhidrosis treatment companies profiled in this report include. 

Brickell Biotech Inc.

Allergan PLC

Cynosure

Dermira Inc.

Dermadry Laboratories inc.

GlaxoSmithKline PLC

Sesderma

Miramar Labs Inc.

Ulthera Inc.

Hyperhidrosis Treatment Market Insights

Lucintel forecasts that Botulin Toxin A will remain the largest segment over the forecast period due to its increasing usage in the treatment of focal hyperhidrosis as it is a safe and effective treatment that lasts longer than topical treatments 

Hospitals will remain the largest end use segment and is also expected to witness the highest growth over the forecast period due to ease in offering of hyperhidrosis treatment in hospitals.

North America will remain the largest region due to increasing key players, growing research and development activities and healthcare advancements in the country.

Features of the Hyperhidrosis Treatment Market

Market Size Estimates: Hyperhidrosis treatment market size estimation in terms of value ($B)

Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.

Segmentation Analysis: Hyperhidrosis treatment market size by various segments, such as treatment type, hyperhidrosis type, distribution channel, end user and region ($B)

Regional Analysis: Hyperhidrosis treatment market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.

Growth Opportunities: Analysis on growth opportunities in different by treatment type, hyperhidrosis type, distribution channel, end user, and region.

Strategic Analysis: This includes M&A, new product development, and competitive landscape for the hyperhidrosis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the hyperhidrosis treatment market size?

Answer: The global hyperhidrosis treatment market is expected to reach an estimated $xx billion by 2028.

Q2. What is the growth forecast for hyperhidrosis treatment market?

Answer: The global hyperhidrosis treatment market is expected to grow with a CAGR of 4% to 6% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the hyperhidrosis treatment market?

Answer: The major drivers for this market are growing prevalence of depression and anxiety among individuals, increasing population, and rising advanced and efficient treatment.

Q4. What are the major segments for hyperhidrosis treatment market?

Answer: The future of the global hyperhidrosis treatment market looks promising with opportunities in the hospitals, ambulatory surgical centers and other market.

Q5. Who are the key hyperhidrosis treatment companies?

Answer: Some of the key hyperhidrosis treatment companies are as follows:

Brickell Biotech Inc.

Allergan PLC

Cynosure

Dermira Inc.

Dermadry Laboratories inc.

GlaxoSmithKline PLC

Sesderma

Miramar Labs Inc.

Ulthera Inc.

Q6. Which hyperhidrosis treatment segment will be the largest in future?

Answer: Lucintel forecasts that botulin toxin A will remain the largest segment over the forecast period due to its increasing usage in the treatment of focal hyperhidrosis as it is a safe and effective treatment that lasts longer than topical treatments.

Q7. In hyperhidrosis treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing key players, growing research and development activities and healthcare advancements in the country.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q1. What are some of the most promising, high-growth opportunities for the hyperhidrosis treatment market by treatment type (botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others), hyperhidrosis type (axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others), distribution channel (hospital pharmacies, retail pharmacies and online pharmacies), end user (hospitals, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q2. Which segments will grow at a faster pace and why?
  • Q3. Which region will grow at a faster pace and why?
  • Q4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q5. What are the business risks and competitive threats in this market?
  • Q6. What are the emerging trends in this market and the reasons behind them?
  • Q7. What are some of the changing demands of customers in the market?
  • Q8. What are the new developments in the market? Which companies are leading these developments?
  • Q9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents  

1. Executive Summary

2. Global Hyperhidrosis Treatment Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges 

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Hyperhidrosis Treatment Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Hyperhidrosis Treatment Market by Treatment Type 
    • 3.3.1: Botulinum Toxin A
    • 3.3.2: Iontophoresis
    • 3.3.3: Surgical Treatments
    • 3.3.4: Topical Treatments
    • 3.3.5: Non-surgical Microwave Energy Destruction of Sweat Glands
    • 3.3.6: Others
  • 3.4: Global Hyperhidrosis Treatment Market by Hyperhidrosis Type
    • 3.4.1: Axillary Hyperhidrosis
    • 3.4.2: Palmar Hyperhidrosis
    • 3.4.3: Plantar Hyperhidrosis
    • 3.4.4: Others
  • 3.5: Global Hyperhidrosis Treatment Market by Distribution Channel
    • 3.5.1: Hospital pharmacies
    • 3.5.2: Retail pharmacies
    • 3.5.3: Online pharmacies
  • 3.6: Global Hyperhidrosis Treatment Market by End User
    • 3.6.1: Hospitals
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Others (Dermatology Clinics and Cosmetic Centers)

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Hyperhidrosis Treatment Market by Region
  • 4.2: North American Hyperhidrosis Treatment Market
    • 4.2.1: North American Hyperhidrosis Treatment Market by Treatment Type: botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others
    • 4.2.2: North American Hyperhidrosis Treatment Market by Hyperhidrosis Type: axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others
  • 4.3: European Hyperhidrosis Treatment Market
    • 4.3.1: European Hyperhidrosis Treatment Market by Treatment Type: botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others
    • 4.3.2: European Hyperhidrosis Treatment Market by Hyperhidrosis Type: axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others
  • 4.4: APAC Hyperhidrosis Treatment Market 
    • 4.4.1: APAC Hyperhidrosis Treatment Market by Treatment Type: botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others
    • 4.4.2: APAC Hyperhidrosis Treatment Market by Hyperhidrosis Type: axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others
  • 4.5: ROW Hyperhidrosis Treatment Market 
    • 4.5.1: ROW Hyperhidrosis Treatment Market by Treatment Type: botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others
    • 4.5.2: ROW Hyperhidrosis Treatment Market by Hyperhidrosis Type: axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis 

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Hyperhidrosis Treatment Market by Treatment Type
    • 6.1.2: Growth Opportunities for the Global Hyperhidrosis Treatment Market by Hyperhidrosis Type
    • 6.1.3: Growth Opportunities for the Global Hyperhidrosis Treatment Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Hyperhidrosis Treatment Market by End User
    • 6.1.5: Growth Opportunities for the Global Hyperhidrosis Treatment Market by Region
  • 6.2: Emerging Trends in the Global Hyperhidrosis Treatment Market 
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Hyperhidrosis Treatment Market 
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hyperhidrosis Treatment Market 
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Brickell Biotech Inc.
  • 7.2: Allergan PLC.
  • 7.3: Cynosure
  • 7.4: Dermira Inc
  • 7.5: Dermadry Laboratories Inc
  • 7.6: GlaxoSmithKline PLC
  • 7.7: Sesderma
  • 7.8: Miramar Labs Inc
  • 7.9: Ulthera Inc   .